Polyphenols-gut Microbiota Interplay and Brain Neuromodulation

Overview

Journal Neural Regen Res

Date 2018 Oct 17

PMID 30323120

Citations 79

Authors

Stefania Filosa

Francesco Di Meo

Stefania Crispi

Affiliations

Soon will be listed here.

Abstract

Increasing evidence suggests that food ingested polyphenols can have beneficial effects in neuronal protection acting against oxidative stress and inflammatory injury. Moreover, polyphenols have been reported to promote cognitive functions. Biotransformation of polyphenols is needed to obtain metabolites active in brain and it occurs through their processing by gut microbiota. Polyphenols metabolites could directly act as neurotransmitters crossing the blood-brain barrier or indirectly by modulating the cerebrovascular system. The microbiota-gut-brain axis is considered a neuroendocrine system that acts bidirectionally and plays an important role in stress responses. The metabolites produced by microbiota metabolism can modulate gut bacterial composition and brain biochemistry acting as neurotransmitters in the central nervous system. Gut microbiota composition can be influenced by dietary ingestion of natural bioactive molecules such as probiotics, prebiotics and polyphenol. Microbiota composition can be altered by dietary changes and gastrointestinal dysfunctions are observed in neurodegenerative diseases. In addition, several pieces of evidence support the idea that alterations in gut microbiota and enteric neuroimmune system could contribute to onset and progression of these age-related disorders. The impact of polyphenols on microbiota composition strengthens the idea that maintaining a healthy microbiome by modulating diet is essential for having a healthy brain across the lifespan. Moreover, it is emerging that they could be used as novel therapeutics to prevent brain from neurodegeneration.

Citing Articles

Polyphenols and Microbiota Modulation: Insights from Swine and Other Animal Models for Human Therapeutic Strategies.

Anghel A, Taranu I, Ortan A, Marcu Spinu S, Dragoi Cudalbeanu M, Rosu P Molecules. 2025; 29(24.

PMID: 39770115 PMC: 11678809. DOI: 10.3390/molecules29246026.

Polyphenols: From Classification to Therapeutic Potential and Bioavailability.

Ciupei D, Colisar A, Leopold L, Stanila A, Diaconeasa Z Foods. 2025; 13(24.

PMID: 39767073 PMC: 11675957. DOI: 10.3390/foods13244131.

Dietary Strategies to Mitigate Alzheimer's Disease: Insights into Antioxidant Vitamin Intake and Supplementation with Microbiota-Gut-Brain Axis Cross-Talk.

Wan Ngah W, Ahmad H, Ankasha S, Makpol S, Tooyama I Antioxidants (Basel). 2025; 13(12.

PMID: 39765832 PMC: 11673287. DOI: 10.3390/antiox13121504.

Plant-based probiotic foods: current state and future trends.

DAlmeida A, Neta A, de Andrade-Lima M, de Albuquerque T Food Sci Biotechnol. 2024; 33(15):3401-3422.

PMID: 39493382 PMC: 11525375. DOI: 10.1007/s10068-024-01674-1.

The Role of Dietary Ingredients and Herbs in the Prevention of Non-Communicable Chronic Liver Disease.

Mackow M, Dziubyna T, Jamer T, Slivinskyi D, Pytrus T, Neubauer K Nutrients. 2024; 16(20).

PMID: 39458499 PMC: 11510335. DOI: 10.3390/nu16203505.

References

Sampson T, Debelius J, Thron T, Janssen S, Shastri G, Ilhan Z . Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease. Cell. 2016; 167(6):1469-1480.e12. PMC: 5718049. DOI: 10.1016/j.cell.2016.11.018. View

Jiang H, Zhang X, Yu Z, Zhang Z, Deng M, Zhao J . Altered gut microbiota profile in patients with generalized anxiety disorder. J Psychiatr Res. 2018; 104:130-136. DOI: 10.1016/j.jpsychires.2018.07.007. View

Nzakizwanayo J, Dedi C, Standen G, MacFarlane W, Patel B, Jones B . Escherichia coli Nissle 1917 enhances bioavailability of serotonin in gut tissues through modulation of synthesis and clearance. Sci Rep. 2015; 5:17324. PMC: 4663480. DOI: 10.1038/srep17324. View

Cryan J, Dinan T . Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012; 13(10):701-12. DOI: 10.1038/nrn3346. View

Finegold S, Downes J, Summanen P . Microbiology of regressive autism. Anaerobe. 2011; 18(2):260-2. DOI: 10.1016/j.anaerobe.2011.12.018. View

Rastmanesh R . High polyphenol, low probiotic diet for weight loss because of intestinal microbiota interaction. Chem Biol Interact. 2010; 189(1-2):1-8. DOI: 10.1016/j.cbi.2010.10.002. View

Laranjinha J, Santos R, Lourenco C, Ledo A, Barbosa R . Nitric oxide signaling in the brain: translation of dynamics into respiration control and neurovascular coupling. Ann N Y Acad Sci. 2012; 1259:10-8. DOI: 10.1111/j.1749-6632.2012.06582.x. View

Carmody R, Turnbaugh P . Host-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics. J Clin Invest. 2014; 124(10):4173-81. PMC: 4191041. DOI: 10.1172/JCI72335. View

Brandscheid C, Schuck F, Reinhardt S, Schafer K, Pietrzik C, Grimm M . Altered Gut Microbiome Composition and Tryptic Activity of the 5xFAD Alzheimer's Mouse Model. J Alzheimers Dis. 2016; 56(2):775-788. DOI: 10.3233/JAD-160926. View

10.

Biagi E, Franceschi C, Rampelli S, Severgnini M, Ostan R, Turroni S . Gut Microbiota and Extreme Longevity. Curr Biol. 2016; 26(11):1480-5. DOI: 10.1016/j.cub.2016.04.016. View

11.

Bondonno C, Yang X, Croft K, Considine M, Ward N, Rich L . Flavonoid-rich apples and nitrate-rich spinach augment nitric oxide status and improve endothelial function in healthy men and women: a randomized controlled trial. Free Radic Biol Med. 2011; 52(1):95-102. DOI: 10.1016/j.freeradbiomed.2011.09.028. View

12.

Di Meo F, Donato S, Di Pardo A, Maglione V, Filosa S, Crispi S . New Therapeutic Drugs from Bioactive Natural Molecules: The Role of Gut Microbiota Metabolism in Neurodegenerative Diseases. Curr Drug Metab. 2018; 19(6):478-489. DOI: 10.2174/1389200219666180404094147. View

13.

Ho L, Ono K, Tsuji M, Mazzola P, Singh R, Pasinetti G . Protective roles of intestinal microbiota derived short chain fatty acids in Alzheimer's disease-type beta-amyloid neuropathological mechanisms. Expert Rev Neurother. 2017; 18(1):83-90. PMC: 5958896. DOI: 10.1080/14737175.2018.1400909. View

14.

Marin L, Miguelez E, Villar C, Lombo F . Bioavailability of dietary polyphenols and gut microbiota metabolism: antimicrobial properties. Biomed Res Int. 2015; 2015:905215. PMC: 4352739. DOI: 10.1155/2015/905215. View

15.

Duenas M, Munoz-Gonzalez I, Cueva C, Jimenez-Giron A, Sanchez-Patan F, Santos-Buelga C . A survey of modulation of gut microbiota by dietary polyphenols. Biomed Res Int. 2015; 2015:850902. PMC: 4352430. DOI: 10.1155/2015/850902. View

16.

Yunes R, Poluektova E, Dyachkova M, Klimina K, Kovtun A, Averina O . GABA production and structure of gadB/gadC genes in Lactobacillus and Bifidobacterium strains from human microbiota. Anaerobe. 2016; 42:197-204. DOI: 10.1016/j.anaerobe.2016.10.011. View

17.

OMahony S, Clarke G, Borre Y, Dinan T, Cryan J . Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav Brain Res. 2014; 277:32-48. DOI: 10.1016/j.bbr.2014.07.027. View

18.

Figueira I, Garcia G, Pimpao R, Terrasso A, Costa I, Almeida A . Polyphenols journey through blood-brain barrier towards neuronal protection. Sci Rep. 2017; 7(1):11456. PMC: 5597593. DOI: 10.1038/s41598-017-11512-6. View

19.

Scheperjans F, Aho V, Pereira P, Koskinen K, Paulin L, Pekkonen E . Gut microbiota are related to Parkinson's disease and clinical phenotype. Mov Disord. 2014; 30(3):350-8. DOI: 10.1002/mds.26069. View

20.

Szapacs M, Mathews T, Tessarollo L, Lyons W, Mamounas L, Andrews A . Exploring the relationship between serotonin and brain-derived neurotrophic factor: analysis of BDNF protein and extraneuronal 5-HT in mice with reduced serotonin transporter or BDNF expression. J Neurosci Methods. 2004; 140(1-2):81-92. DOI: 10.1016/j.jneumeth.2004.03.026. View